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Inactivation of one X chromosome in female mammals (XX) compensates for the reduced dosage of
X-linked gene expression in males (XY). However, the inner cell mass (ICM) of mouse preimplantation
blastocysts and their in vitro counterparts, pluripotent embryonic stem cells (ESCs), initially maintain
two active X chromosomes (XaXa). Random X chromosome inactivation (XCI) takes place in the ICM
lineage after implantation or upon differentiation of ESCs, resulting in mosaic tissues composed of two
cell types carrying either maternal or paternal active X chromosomes. While the status of XCI in human
embryos and ICMs remains unknown, majority of human female ESCs show non-random XCI.
We demonstrate here that rhesus monkey ESCs also display monoallelic expression and methylation
of X-linked genes in agreement with non-random XCI. However, XIST and other X-linked genes were
expressed from both chromosomes in isolated female monkey ICMs indicating that ex vivo pluripotent
cells retain XaXa. Intriguingly, the trophectoderm (TE) in preimplantation monkey blastocysts also
expressed X-linked genes from both alleles suggesting that, unlike the mouse, primate TE lineage does
not support imprinted paternal XCI. Our results provide insights into the species-speciﬁc nature of XCI
in the primate system and reveal fundamental epigenetic differences between in vitro and ex vivo
primate pluripotent cells.
& 2012 Elsevier Inc. All rights reserved.Introduction
X chromosome inactivation is believed to be an essential
mechanism regulating the dosage compensation of X-linked
genes in eutherian mammals so that females with two X chromo-
somes do not overexpress X-linked genes compared to males
(Lyon, 1961). XCI is initiated during early mouse preimplantation
embryo development, where the paternally inherited X chromo-
some is silenced in early cleaving embryos. However at the
blastocyst stage, paternal X chromosome is transiently reacti-
vated in the ICM, resulting in two active X chromosomes (XaXa).
However, paternally imprinted XCI is maintained in the mouse TEll rights reserved.
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239, USA.lineage (Hajkova and Surani, 2004; Okamoto et al., 2004). Random
XCI takes place in the ICM lineage after implantation, at about the
time of gastrulation, through epigenetic silencing involving
XIST RNA coating of the inactive X in cis (Panning et al., 1997;
Penny et al., 1996). Thus, somatic tissues in females are mosaic
composed of two cell types expressing from one or the other
X chromosome.
In contrast to this strict X gene dosage compensation mechan-
ism in the mouse, approximately 15% of X-linked genes in
humans escape XCI and are expressed biallelically in females
(Carrel and Willard, 2005). Why and how these escape genes are
transcribed from a largely inactivated X chromosome is not fully
understood. In addition, the existence of paternally imprinted XCI
in the TE lineage in humans remains controversial, where few
studies reported conﬂicting ﬁndings (Moreira de Mello et al.,
2010; Zeng and Yankowitz, 2003).
ESCs are in vitro pluripotent cell lines derived from the ICM of
preimplantation blastocysts in several species, including mice,
nonhuman primates, and humans (Evans and Kaufman, 1981;
Martin, 1981; Thomson et al., 1995; 1998). ESCs can be maintained
and propagated indeﬁnitely in a pluripotent state providing an
M. Tachibana et al. / Developmental Biology 371 (2012) 146–155 147unlimited supply of undifferentiated cells for cell replacement
therapy. However, isolation of stable mouse female ESCs remains
problematic due to frequent loss of one of the two X chromosomes
(Zvetkova et al., 2005). In a few existing stable mouse XX ESCs, both
X chromosomes remain active and XCI is initiated upon differentia-
tion (Nichols and Smith, 2009).
In contrast to the mouse, isolation of male and female primate
ESCs is equally efﬁcient and loss of one of the two X chromosomes
is relatively rare in human female ESCs. However, a majority of
human female ESC lines appear to have undergone XCI in an
undifferentiated state (Shen et al., 2008; Silva et al., 2008).
Moreover, these human ESCs often exhibit monoallelic expression
of X-linked genes, suggesting either imprinted XCI, as seen in the
mouse TE lineage (Shen et al., 2008), or random XCI followed by
the clonal selection of the one or another populations during ESC
isolation and culture.
It remains unclear whether such fundamental differences
between mouse and primate ESCs reﬂect species-speciﬁc differ-
ences in the tissue of origin. For example, XCI in human ESCs
could simply reﬂect the pre-existing status in the parental ICMs.
Alternatively, XCI may indicate epigenetic instability during
isolation and long-term culture of human ESCs. Our recent study
demonstrated that monkey ESCs are unable to contribute to
chimeras upon injection into host blastocysts (Tachibana et al.,
2012). However, transplanted ICMs formed viable fetuses while
sharing the TE compartment with host blastocysts. These results
necessitate further investigations into genetic and epigenetic
mechanisms responsible for such drastic differences in develop-
mental potential of primate ICMs vs. ESCs. Currently, few studies
are available on X inactivation status and timing in human
embryos (Okamoto et al., 2011; van den Berg et al., 2009). This
is in large part, due to restrictions on human embryo research and
the lack of relevant genetic markers that would allow discrimina-
tion of two X chromosomes.
To address this gap in the knowledge, we carried out a
comprehensive analysis of XCI on a clinically relevant nonhuman
primate model. We investigated allele speciﬁc expression and
methylation of several X-linked genes in female rhesus macaque
(Macaca Mulatta) blastocysts, focusing particularly on the ICM
and TE. We also extended our studies to rhesus monkey ESCs
derived from fertilized embryos or experimental pluripotent stem
cells derived by reprogramming of somatic cells using somatic
cell nuclear transfer (SCNT) or iPS (induced pluripotent stem) cell
approaches.Materials and methods
Animals
All animal procedures were approved by the Institutional
Animal Care and Use Committee (AICUC) at the ONPRC/OHSU.
Production of monkey embryos, ICM and TE isolation and gender
determination
Rhesus macaque embryos were generated by intracytoplasmic
sperm injection (ICSI) and cultured to the blastocyst stage as
described previously (Wolf et al., 2004). In vivo developmental
competence of these embryos was previously demonstrated by
birth of healthy rhesus offspring (Tachibana et al., 2009; 2012;
Wolf et al., 2004). Intact ICMs from various stage blastocysts were
isolated by immunosurgery (Mitalipov et al., 2006). In brief, zona
pellucidae were digested by short (10 s) treatment with 0.5%
protease. Blastocysts were then incubated in anti monkey whole
serum (Sigma) for 30 min at 37 1C, washed three times withculture medium and transferred into guinea pig complement
(Sigma) for 30 min. Blastocysts were then gently pipetted with a
small-bore pipette to disperse lysed TE cells and isolate intact
ICMs. For the TE isolation, a zona-free blastocyst was held with
a micropipette near the ICM. Next, a sequential laser pulse
(Staccato laser www.hamiltonthorne.com) was ﬁred across the
boundary between the ICM and TE while the TE part was pulled
away with a second pipette until complete separation. Unutilized
ICM or TE cells were used for gender determination using PCR
approach. Cells were collected into 0.2 ml PCR tubes containing
4 ul of PicoPures DNA (Arcturus Bioscience) extraction buffer,
and X- and Y-linked zinc ﬁnger protein genes (ZFX and ZFY) were
ampliﬁed as previously described (Mitalipov et al., 2007). Female
samples produced 1149 bp fragment while male samples con-
tained an additional 771 bp fragment.
Derivation, culture and characterization of monkey iPS cells
Primary cultures of ﬁbroblasts were established from rhesus
macaque skin biopsies. Fibroblasts in the log growth phase were
transduced with retroviral vectors carrying 4 transcription factors as
previously described (Takahashi et al., 2007; Wu et al., 2009).
Brieﬂy, plasmids (pMXs–hOCT4, pMXs–hSOX2, pMXs–hKLF4 and
pMXs–hC–MYC, Cell Biolabs, Inc. San Diego, CA) were packaged into
retroviral particles by transfection into Platinum-A Retroviral Packa-
ging Cells using Fugenes HD Transfection Reagent (Roche, Indiana-
polis, IN). Transduction of ﬁbroblasts was performed three times at
24 h intervals, followed by seeding of cells onto feeder layers of
mitotically inactivated mouse embryonic ﬁbroblasts (mEFs) in ESC
culture medium consisting of DMEM/F12 medium with high glu-
cose, without sodium pyruvate and supplemented with 1% nones-
sential amino acids, 2 mM l-glutamine, 0.1 mM b-mercaptoethanol
and 15% FBS (Mitalipov et al., 2006). The transduced cells were
maintained at 37 1C in 3% CO2, 5% O2 and balance N2 for up to
4 weeks or until colonies of cells with a morphology similar to ESCs
appeared. Each colony was then individually isolated and manually
propagated using standard ESC culture techniques as previously
described (Byrne et al., 2007; Mitalipov et al., 2006; Sparman et al.,
2009).
Expression of ESC markers in iPS cells was detected by
immunocytochemistry as previously described (Mitalipov et al.,
2006; Sparman et al., 2009). Primary antibodies for OCT4, SSEA-4,
TRA-1-60 and TRA-1-81 were from Santa Cruz Biotechnology Inc.
and NANOG was from R-D Systems.
Comparative microarray analysis of mRNA proﬁles in iPS
cells and their IVF or SCNT controls was carried out using
the Affymetrix Rhesus Macaque Genome array as previously
described (Sritanaudomchai et al., 2010). RNA samples were
converted to labeled cRNA and hybridized to GeneChip Rhesus
Macaque Genome Arrays (Affymetrix, Inc.). Gene-Chip operating
system version 1.4 software (Affymetrix) was used to process
images and generated probe level measurements. Microarray
data, including CEL and CHP ﬁles, can be accessed at the Gene
Expression Omnibus (GEO: GSE36252), http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?token=zxcvbegqooeoalu&acc=GSE36252.
Processed image ﬁles were normalized across arrays using the
robust multichip average algorithm (Irizarry et al., 2003) and log
transformed (base 2) to perform direct comparisons of probe set
values between samples. GeneSifter (VizX Labs, Seattle, WA)
microarray expression analysis software was used to identify
differentially expressed transcripts. For a given comparison, IVF-
derived ESCs were selected as the baseline reference, and tran-
scripts that exhibited various fold change relative to the baseline
were considered differentially expressed. To facilitate in-depth
comparisons, processed image ﬁles were normalized with the
robust multichip average algorithm and log transformed (base 2)
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sion data were analyzed by pairwise differences determined with
the Student-t-test (Po0.05).
Qualitative and quantitative reverse transcription (RT)–PCR analysis
Total RNA was extracted from ESCs and preimplantation
embryos using TRIzols Reagent (Invitrogen) and PicoPure
TM
RNA
extraction kit (Arcturus Bioscience), respectively. DNAse treated
RNA was converted to cDNA using the SuperScript III ﬁrst strand
synthesis system for RT-PCR (Invitrogen) according to the man-
ufacturer’s instructions. The ﬁrst strand cDNA was ampliﬁed by
PCR using XIST speciﬁc primers for RT or qPCR, as previously
described (Sparman et al., 2009). The primers for G6PD qPCR
were; F-50 atgaaaggtgggatggagtg 30 and R-50 actgctggtggaagatgtca
30. qPCR was performed using 7500 Fast system with Fast SYBRs
Green PCR master Mix (Applied Biosystems). Expression of house-
keeping GAPDH was used as a control.
Generation of heterozygous embryos and allele-speciﬁc expression
analysis of XIST and X-linked genes
To generate heterozygote embryos, rhesus macaque males and
females were pre-screened for SNPs within transcribed regions of
XIST and X-linked genes as previously described (Fujimoto et al.,
2006). Information for primers and SNP positions is available in
Supplementary Material, Tables S1 and S2. Oocytes and sperm from
animals carrying informative alleles were then collected
and embryos were generated in vitro by ICSI as described previously
(Wolf et al., 2004). RT-PCR amplicons were subcloned and expressed
alleles were determined by direct sequence analysis of a minimum
10 individual clones. In brief, PCR reaction was carried out using PCR
super mix high-ﬁdelity DNA polymerase (Invitrogen) containing
0.5 mM of each primer (ﬁnal volume 25 ml). PCR products were
sequenced and the expressing alleles were determined using the
Sequencher v. 4.7 software (GeneCodes).
Bisulﬁte genomic sequencing
Genomic (g)DNA was extracted from ESCs and embryonic cells
using a Gentra PUREGENEs DNA Puriﬁcation (Qiagen) or Pico-
Pures DNA kit (Arcturus Bioscience), respectively. gDNA was
subjected to bisulﬁte treatment using a MethylCode
TM
Bisulﬁte
Conversion Kit (Invitrogen, MECOV-50) according to the manu-
facturer’s instructions. In brief, 500 ng of total gDNA was used for
each reaction. For embryos, gDNA was pooled from up to twenty
ICMs while for TEs three samples were combined to generate
sufﬁcient DNA for a single bisulﬁte reaction. Bisulﬁte sequencing
PCR primers were designed using the Methyl Primer Express
Software v1.0 (Applied Biosystems). Information for primers and
PCR conditions is available in Supplementary Material, Tables S4.
PCR reactions were performed using PCR super mix high-ﬁdelity
DNA polymerase (Invitrogen) containing 0.5 mM of each primer
(ﬁnal volume 25 ml). PCR products were then sub-cloned using
TOPOs TA cloning kit. Fifteen to twenty-ﬁve colonies were
randomly selected and sequenced. Sequences were then analyzed
using a web-based QUantiﬁcation tool for Methylation Analysis
(QUMA) (http://quma.cdb.riken.jp/). Methylation proﬁles were
presented as a CpG map with white and black dots indicating
unmethylated and methylated CpG dinucleotides, respectively.
Statistical analysis
Statistical analyses were performed using ANOVA and Fisher’s
PLSD with Statview Software (SAS Institute, Inc.) with statistical
signiﬁcance set at 0.05.Results
XCI in monkey somatic cells
To establish reliable markers of XCI, we initially analyzed XCI
status in somatic tissues derived from fetal and adult rhesus
macaques. Based on the evidence that expression of XIST is critical
for initiation of X chromosome silencing and early XCI readout
(Diaz-Perez et al., 2005; Lucchesi et al., 2005), we initially
detected transcripts of XIST. As expected, conventional reverse-
transcription (RT)-PCR detected XIST expression in female somatic
cells but not in males (Fig. 1A). We next screened and identiﬁed
informative heterozygous fetal and adult tissues based on single
nucleotide polymorphisms (SNPs) within transcribed regions for
XIST. Information on SNP positions and primers is presented in
Supplementary Information (Tables S1 and S2). Allele speciﬁc
expression analysis demonstrated the presence of XIST transcripts
from both X-chromosomes in female tissues (Tables S3). This was
an expected outcome assuming that female tissues represent a
mixture of cells with random XCI. We also analyzed allele-speciﬁc
expression of X-linked ZNF41 and FMR1, genes shown to undergo
silencing in humans (Carrel and Willard, 2005). Similar to XIST,
transcripts from both X-chromosomes were detected in female
tissues for both genes (Tables S3).
Since expression of X-linked genes in a mixed population of
female tissues displaying random XCI (XiXaþXaXi) would be
similar to a scenario in which cells possess two active X chromo-
somes (XaXa), we explored DNA methylation as an additional
epigenetic marker of XCI. It is generally accepted that XIST
promoter region harboring CpG region is methylated on a silent
XIST but otherwise transcriptionally active X chromosome (Norris
et al., 1994). In contrast, this region is unmethylated on the
opposite allele resulting in the transcription of XIST but silencing
of other X-linked genes on this chromosome (Beard et al., 1995;
Norris et al., 1994). We carried out methylation analysis of XIST by
bisulﬁte genomic sequencing and focused on the two CpG islands
located within promoter/exon 1, based on previously reported
human studies (Hendrich et al., 1997; Poplinski et al., 2010; Shen
et al., 2008). Information for primers for bisulﬁte sequencing and
PCR conditions are presented in Supplementary Information
(Tables S4). Male somatic tissues displayed nearly complete
methylation in both CpG islands, in agreement with the tran-
scriptional silencing of XIST but otherwise active single X. In
female tissues, approximately 50% of analyzed clones were
methylated for both islands (Fig. 1B). These results support the
conclusion that methylation status of XIST correlates with its
expression and can be used to differentiate random XCI from two
active X chromosomes.
We also extended our methylation studies to G6PD, the gene
also known to undergo XCI (Carrel and Willard, 2005; Keohane
et al., 1996). In contrast to XIST, methylation of most X-linked
genes is associated with their transcriptional silencing on
the chromosome they reside on. As expected, male tissues were
completely unmethylated within G6PD, consistent with the
notion that male cells possess single but active X chromosome
(Fig. 1C). In contrast, approximately half of the analyzed clones in
female tissues exhibited heavy methylation, suggesting that
female somatic cells have undergone random XCI and that in
any given cell, the X-linked genes are transcribed from one active
X chromosome.
XCI in primate blastocysts
Next we explored XCI in monkey blastocysts produced in vitro
using our conventional approaches (Wolf et al., 2004). We
analyzed XIST expression, separately, in the ICM and TE isolated
Fig. 1. Expression and methylation of X-linked genes in rhesus macaque somatic cells. (A) Expression of XIST was detected by RT-PCR in female but not male ﬁbroblasts.
Housekeeping gene GAPDH was used as a control. (B) Methylation analysis of XIST promoter region by bisulﬁte sequencing. Horizontal bars indicate position of individual
CpG dinucleotides within each region. The islands 1 and 2 consisting of six and ten CpG sites, respectively, were fully methylated in male ﬁbroblasts indicating
transcriptional silencing of XIST. However, approximately half of the clones in female ﬁbroblasts were unmethylated suggesting expression of XIST from one X
chromosome. (C) Methylation proﬁle of X-linked G6PD in ﬁbroblasts. A total of twenty-eight CpG sites were analyzed that were unmethylated in male samples in
agreement with conclusion that males possess single but active X. As expected, half of the clones in female samples were methylated suggesting that one X chromosome is
silenced.
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assisted biopsy. We also used a portion of biopsied TE samples
to differentiate male and female blastocysts using PCR-based
gender analysis based on size differences in the amplicons of
the X- and Y-linked zinc ﬁnger protein genes (ZFX and ZFY)
(Mitalipov et al., 2007). Conventional RT-PCR analysis revealed
the presence of XIST transcripts in all female ICMs (Fig. 2A).
Interestingly, we also detected XIST expression in 4 out of 5 tested
male ICMs, which was in agreement with previous observations
in human embryos (Okamoto et al., 2011; Ray et al., 1997). Next,
we conducted quantitative real-time (q)PCR analysis to determine
levels of XIST expression during developmental progression of
monkey blastocysts. In female ICMs, XIST expression levels
gradually increased from early blastocysts (EB, day 6 post ferti-
lization) to expanded blastocysts (ExB, day 8) and hatched
blastocysts (HB, day 11). In contrast, male ICMs exhibited low
levels of XIST that did not change during progression through
blastulation stages (Fig. 2A). Female TE cells were assayed for
expanded blastocysts only and displayed signiﬁcant levels of XIST
expression similar to that seen for ICMs in hatched blastocysts.
To further deﬁne XCI status in the ICM and TE of expanded
blastocysts, we carried out methylation studies of XIST and G6PD
as described above. Due to insufﬁcient DNA amounts for bisulﬁte
sequencing, up to twenty individual ICMs or three TEs were
pooled for each assay. Both XIST CpG islands were hypomethy-
lated in female ICMs (Fig. 2B), consistent with biallelic expression
of XIST. In contrast, majority of clones in male ICMs showed
sporadic methylation patterns (Fig. 2B). Levels of XIST methyla-
tion in male ICMs were notably lower than that seen in malesomatic cells. This observation correlates with low but detectable
XIST expression in male ICMs. XIST methylation patterns were
comparable for both male and female TE samples, with heavy
methylation in most clones for the island 1 while approximately
half clones in the island 2 were sporadically methylated (Fig. 2B).
In contrast, G6PD gene was unmethylated in the ICM and TE cells
of both in female and male embryos, suggesting that this gene is
transcribed from both X chromosomes (Fig. 2C).
We also carried out allele-speciﬁc expression analysis of XIST,
ZNF41 and FMR-1 in individual ICMs and TEs based on SNPs
identiﬁed in sperm and oocyte donors. We collected gametes from
animals carrying informative alleles and generated heterozygous
embryos as described previously (Wolf et al., 2004). As expected,
male ICMs expressed these genes from the maternal allele and
transcripts from both X chromosomes were detected in female ICMs
(Table 1 and Fig. S1). Similar to the ICM, both maternal and paternal
transcripts of XIST and ZNF41 were detected in TE samples, while
FMR1 was expressed monoallelically from the paternal allele
(Table 1). We also recovered placental tissues from two midgestation
rhesus pregnancies and conﬁrmed biallelic expressions of XIST and
ZNF41 (Table 1).
In summary, these results indicate that XIST is expressed at
signiﬁcantly higher levels in female ICMs compared to male
embryos. Based on the negative correlation between XISTmethyla-
tion and expression seen in monkey somatic cells, lack of methyla-
tion marks suggests that XIST is expressed biallelically in female
ICMs. We previously demonstrated that immunosurgically isolated
monkey ICMs contain NANOG expressing epiblast and GATA-6
positive primitive endoderm cells (Tachibana et al., 2012). It is
Fig. 2. Expression and methylation of XIST and G6PD in monkey ICM and TE samples. (A) XIST expression in isolated ICMs was analyzed by qualitative and quantitative PCR.
RT-PCR detected strong XIST expression in all female ICM samples while in most male ICMs expression was moderate. Levels of XIST expression were also analyzed by
qPCR. In female ICMs, XIST expression levels increased with developmental progression from early (EB) to expanded (ExB) and hatched blastocysts (HB). Male ICMs
exhibited low levels of XIST that did not change throughout blastulation. Similar to ICMs, female TE cells also expressed signiﬁcant levels of XIST. Abbreviations: MW, MF,
FF, neg, EB, ExB, HB, ICM and TE, indicate Molecular Weight, Male Fibroblasts, Female Fibroblasts, negative control, Early Blastocysts, Expanded Blastocysts, Hatched
Blastocysts, Inner Cell Mass and Trophectoderm, respectively. (B) XIST methylation proﬁles in the ICM and TE. In female ICMs few clones in the island 1 were sporadically
methylated and the island 2 was completely unmethylated. In contrast, more than half of the clones were methylated in male ICMs and both gender TE samples. (C) G6PD
promoter was unmethylated in both male and female samples.
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monkey ICMs.
Lack of G6PD methylation also supports the model that both
X-chromosomes are transcriptionally active in monkey ICMs. Incontrast, partial XIST methylation in the TE suggests that the
process of XCI has been initiated in the TE lineage. However,
allele-speciﬁc expression analysis of TE and placental samples
suggests that XCI in the primate TE lineage is not strictly paternal.
Table 1
Allele-speciﬁc expression analysis of XIST, ZNF41 and FMR1 in the ICM, TE and placenta.
Gene SNPa ICM #1 ICM #2 ICM #3 ICM #4 ICM #5 TE #1 TE #2 Placenta #1 Placenta #2
XIST A/G 16344 Bi Bi – Bi
m5/p9 m3/p9 m4/p10
A/T 16396 – – – Bi Bi Bi Bi Bi –
m3/p9 m3/p8 m5/p9 m3/p9 m2/p13
A/G 16479 Bi Bi Bi – – – – Bi Bi
m6/p4 m9/p9 m7/p9 m2/p13 m4/p10
ZNF41 C/T 3424 Bi Bi Bi – Bi Bi Bi – –
m2/p8 m4/p8 m1/p10 m11/p3 m1/p13 m10/p5
A/G 3503 Bi Bi Bi – Bi Bi Bi – –
m2/p8 m4/p8 m1/p10 m11/p3 m1/p13 m10/p5
C/T 3535 – – – Bi – – – Bi Bi
m12/p1 m10/p2 m11/p1
FMR1 G/T 2623 – – – Bi – Mono (p) – – –
m8/p6
‘‘–’’ indicates absence of informative SNPs for this sample.
Mono and Bi indicate monoallelic or biallelic expression, respectively.
‘‘m’’ and ‘‘p’’ indicates expression from the maternal and paternal alleles, respectively.
Number after ‘‘p’’ and ‘‘m’’ indicates number of individual clones expressing this particular parental allele.
a Detailed information for each SNP position is presented in Supplementary Material, Table S2.
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We later explored XCI status in several ESC lines derived from
in vitro fertilized (IVF) blastocysts (ORMES lines) (Mitalipov et al.,
2006). In addition, we studied experimental pluripotent stem
cells derived by SCNT (CRES lines) (Byrne et al., 2007; Sparman
et al., 2009). These cell lines were extensively characterized for
expression of pluripotency markers and by in vitro and in vivo
differentiation elsewhere (Byrne et al., 2007; Mitalipov et al.,
2006; Sparman et al., 2009). We also generated monkey iPS cells
(RiPS lines) from the same parental somatic cells that were used
as nuclear donors for SCNT (Tables S5) using retroviral transduc-
tion with vectors carrying OCT4, SOX2, Klf4 and cMYC. All RiPS cell
lines were morphologically indistinguishable from their IVF- or
SCNT-derived counterparts (Byrne et al., 2007; Sparman et al.,
2009) and expressed conventional pluripotency markers includ-
ing OCT4, NANOG, SSEA-4, TRA-1-60 and -1-81 (Fig. S2A). In
addition, we conducted microarray analysis of genome-wide
mRNA proﬁles of iPS cells in comparison to their IVF and SCNT
controls using the Affymetrix Rhesus Macaque Genome array.
Results conﬁrmed that all monkey pluripotent stem cells exhib-
ited similar transcriptional proﬁles (Fig. S2B).
To exclude the possibility that XCI status may change during
long-term culture, all stem cells were analyzed at early passages.
Similar to somatic cells, male pluripotent cells did not express
XIST (Fig. 3A). However, female stem cells displayed signiﬁcant
levels of XIST transcripts comparable to that of female ICMs
(Fig. 3B). We next conducted methylation analysis of stem cell
lines by bisulﬁte sequencing. Approximately half clones in all
female stem cell lines were heavily methylated in XIST and G6PD
promoter regions (Figs. 3C and S3A). These results contrasted
with methylation proﬁles seen in female ICMs but were similar to
female somatic cells. To relate methylation with expression, we
carried expression analysis of G6PD by qPCR (Fig. S3B) and
observed that lack of methylation is associated with increased
expression (Fig. S3C).
Allele-speciﬁc expression of XIST, ZNF41 and FMR1 demonstrated
that all informative female cell lines, regardless of their origin,
expressed these genes from a single X-chromosome (Table 2). In two
IVF-derived cell lines (ORMES-15 and 22), XIST expression was from
the maternal X chromosome, while ZNF41 and FMR1 were tran-
scribed from the opposite paternal X. Similar reciprocal expression
pattern was also seen in CRES and iPS cell lines, although we wereunable to determine parent-of-origin X-chromosomes in these cells
since parental information for adult animals that contributed skin
ﬁbroblasts was unavailable. Interestingly, CRES-3, CRES-4, RiPS-3A
and RiPS-3B were all derived from the same parental skin ﬁbroblasts
established from the 8 years old female #4 (Tables S5). CRES-3,
CRES-4 and RiPS-3A reciprocally expressed these genes from the
same X-chromosomes. However, expression of XIST, ZNF41 and
FMR1 in RIPS-3B was from opposite X chromosomes (Table 2).
Collectively, these results suggest that cultured monkey plur-
ipotent stem cells, irrespective of their origin, underwent XCI.
However, in contrast to somatic cells with random XCI, each stem
cell line represents a population of cells expressing X-linked
genes from a single chromosome.Discussion
Proper X-inactivation is critical for normal development of
female organisms as well as for ESC differentiation and their
utility in regenerative medicine. Yet, a number of unresolved
questions remain regarding XCI in human preimplantation
embryos and ESCs. We here provide a comprehensive analysis
of XCI in monkey blastocysts and cultured pluripotent stem cells
based on methylation and allele-speciﬁc expression of XIST and
other X-linked genes. Prior studies suggested that RNA FISH assay
for XIST, a gold-standard approach that is primarily used in the
mouse, might not be sufﬁcient for validation of XCI in human
embryos and ESCs (Minkovsky et al., 2012; Shen et al., 2008). We
established that methylation of XIST and G6PD promoter regions
in combination with allele-speciﬁc expression of X-linked genes
can provide an alternative assay for determination of XCI.
Our results indicate that both X chromosomes are active
in monkey ICMs, while even early passage female ESCs have
undergone strictly monoallelic XCI (Fig. S4). These results are in
agreement with reported studies on human ESC lines indicating
that a majority of analyzed cell lines have also undergone XCI
(Shen et al., 2008; Silva et al., 2008).
Analysis of a large number of human ESCs also identiﬁed that
some cell lines retain two active X chromosomes similar to that
seen in the mouse (Silva et al., 2008). However, these cell lines are
unstable and undergo XCI during culture while still remaining
undifferentiated. Another class of human ESCs, apparently, main-
tains XaXa but is unable to initiate proper XCI after differentiation
Fig. 3. X-linked gene expression and methylation in rhesus macaque pluripotent stem cells. (A) XIST expression by conventional RT-PCR was undetectable in male ESCs,
whereas all female lines strongly expressed XIST similar to that seen in somatic cells. Abbreviations: MW, MF, FF, Ri1-B1, Ri1-D1, OR-23, OR-15, OR-22, CR-3, CR-4, Ri2-N3,
Ri2-S1, Ri3-A, Ri3-B and neg, indicate Molecular Weight, Male Fibroblasts, Female Fibroblasts, RiPS1-B1, RiPS1-D1, ORMES-23, ORMES-15, ORMES-22, CRES-3, CRES-4,
RiPS2-N3, RiPS2-S1, RiPS3-A, RiPS3-B and negative control respectively. (B) qPCR based assay demonstrated signiﬁcant levels of XIST expression in all female cell lines.
(C) Approximately half of the clones in all female pluripotent stem cells were methylated in both XIST promoter islands. G6PDmethylation in female stem cells was similar
to XIST indicating XCI.
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XIST expression combined with FISH analysis or enrichment of
histone 3 lysine 27 tri-methylation (H3K27me3). Thus, it is
unclear if XIST and other X-linked genes maintain biallelic
expression in these ESCs.
In contrast, stable mouse XX ESCs maintain two active X
chromosomes that apparently display proper random XCI onlyafter in vitro differentiation (Monkhorst et al., 2008; Payer and
Lee, 2008). However, as pointed above, female ESC lines from
most mouse strains are unstable and rapidly lose one of the X
chromosomes at early passages (Tesar, 2005). This phenomenon
was noticed shortly after the ﬁrst successful derivation of mouse
ESCs, more than two decades ago (Nichols et al., 1990; Robertson
et al., 1983). It remains unclear if chromosomal instability in
Table 2
Allele-speciﬁc expression of XIST, ZNF41 and FMR1 in monkey pluripotent stem cell lines.
Gene SNPa OR-15 OR-22 CRES-3 CRES-4 RiPS2-N3 RiPS2-S1 RiPS3-A RiPS3-B
XIST C/T 13501 – – – – Mono T Mono C – –
A/G 15439 – Mono (m) – – – – – –
C/T 15491 Mono (m) – – – – – – –
C/T 15631 Mono (m) – – – – – – –
A/G 16344 – Mono (m) Mono G Mono G – – Mono G Mono A
A/T 16396 Mono (m) – – – – – – –
A/G 16479 Mono (m) Mono (m) Mono A Mono A – – Mono A Mono G
ZNF41 A/T 1448 – Mono (p) – – Mono A Mono T – –
A/G 2148 – – – – – – – –
C/T 3424 – Mono (p) Mono T Mono T – – Mono T Mono C
A/G 3503 Mono (p) Mono (p) Mono A Mono A – – Mono A Mono G
C/T 3535 – – Mono C Mono C – – Mono C Mono T
A/G 4047 – – – – – – – –
FMR1 G/T 2623 – – – – Mono G Mono T – –
‘‘–’’ indicates absence of informative SNPs for this sample.
Mono and Bi indicate monoallelic and biallelic expression, respectively.
(m) and (p) indicate expression from the maternal or paternal alleles, respectively.
Parental information was only available for IVF-derived OR-15 and OR-22 cell lines.
a Detailed information on SNP positions is presented in Supplementary Material, Table S2.
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mental studies indicated that such aneuploidy compromises
ability of ESCs to generate chimeras and subsequently germ-line
transmission (Robertson et al., 1983; Zvetkova et al., 2005).
Knowledge of XCI in human embryos remains limited despite
its importance for understanding early development and disease.
However, mechanisms regulating XCI during early human embryo
development appears to be different from that in mouse. For
instance, recent FISH-based study reported that both the ICM
and TE of human blastocysts carry active X chromosomes despite
being coated with XIST RNA (Okamoto et al., 2011). Our result in
the monkey blastocysts are in agreement with these observations
and demonstrate that XIST and other X-linked genes are actively
transcribed from both alleles in ICMs and TEs. It also appears that
unlike mouse, there is no imprinted paternal XCI in the monkey
TE lineage supporting prior human observations (Fan and Tran,
2011; Okamoto et al., 2011). Previous studies also showed that
global demethylation in mutant mice does not interfere with
proper XCI suggesting that other mechanisms may also be
involved (Sado et al., 2000; Sado et al., 2004).
Monkey ESCs derived from these ICMs display XCI even at
early passages suggesting that XCI occurs during the derivation of
ESCs. Moreover, we demonstrate a strictly monoallelic expression
of XIST and other X-linked genes in all tested monkey ESCs
suggesting that XCI in these cell lines is not random. Novel
human XaXa ESCs were successfully derived and maintained
under optimal 5% oxygen concentrations mimicking in vivo con-
ditions (Lengner et al., 2010). XIST expression was not detectable
in these ESCs and SNP-chip assay revealed biallelic expression of
X-linked genes. However, we routinely culture monkey embryos
and ESCs at 5% oxygen and it seems that these conditions do not
prevent XCI in monkey ESCs. It should be noted that culture
medium for human ESCs was different than that used for monkey
cells in this study. While our medium contained fetal bovine
serum, human ESC culture medium used LIF and serum replace-
ment (Lengner et al., 2010).
Mouse pluripotent stem cells were also derived from the
epiblast of post-implantation embryos (EpiSCs) (Brons et al.,
2007; Tesar et al., 2007). Interestingly, female EpiSCs display
random XCI but apparently karyotypically are more stable than
female ESCs. Despite their ability to differentiate in vitro or in vivo
into teratomas, EpiSCs display limited ability to contribute tochimeras (Guo et al., 2009; Tesar et al., 2007). Recent studies
have shown that EpiSCs can be reprogrammed into a more
potent (‘‘naive’’) ESC state (Guo et al., 2009). Based on similarities
in XCI and growth requirements, it was suggested that human
ESCs most likely represent epiblast stem cells and naive state
can be restored in human ESCs under conditions developed for
the mouse (Hanna et al., 2010). Particularly, it was demon-
strated that transduction of human ESCs with vectors carrying
KLF4 and OCT4 and cultured with inhibitors of glycogen synthase
kinase 3b (GSK3b) and mitogen-activated protein kinase (ERK1/2)
can reactivate a silent X chromosomes resulting in ESCs with
XaXa (Hanna et al., 2010). However, long-term maintenance of
XaXa in these ESCs appears to depend on constitutive over-
expression of these factors (Buecker et al., 2010; Hanna et al.,
2010).
XCI in monkey pluripotent cells derived using SCNT or iPS-
based reprogramming resemble situation with IVF-derived ESCs
since all analyzed cell lines showed monoallelic XCI. It remains
unclear whether monkey SCNT embryos temporarily reactivate X
in the ICM. In iPS cell lines, monoallelic XCI could simply reﬂect
the origin from a single somatic cell (Mekhoubad et al., 2012).
This is also supported by observation that two iPS cell clones
generated from the same parental ﬁbroblasts displayed opposite
XCI. This allows generation of genetically-identical iPS cells but
expressing different set of X-linked genes similar to that observed
with human iPS cells derived from patients with Rett syndrome
(Amenduni et al., 2011). Long-term culture of pluripotent stem
cells may also induce epigenetic changes affecting maintenance
XCI (Dvash et al., 2010; Mekhoubad et al., 2012; Shen et al., 2008;
Silva et al., 2008).
In summary, we demonstrate the fundamental epigenetic
differences between primate ex vivo pluripotent cells residing in
blastocysts and their in vitro cultured counterparts. How XCI may
affect human or monkey ESC differentiation and engraftment
after transplantation remains unclear. Particularly, given that XCI
in primate ESCs and iPS cells is non-random, rendering cells
expressing X-linked genes from only one X chromosome. It is
likely that similar to the mouse, X inactivation status in monkey
ESCs affects their developmental potential. Thus, it is critical to
understand mechanisms of XCI and to develop optimized culture
conditions that would favor derivation and maintenance of ESCs
with two active X-chromosomes.
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